Small Animal Medicine Online Learning

By the end of this module, the learner will be able to: 

• Define clinical reasoning and explain its fundamental role in everyday veterinary practice. 
• Distinguish between Type 1 (intuitive) and Type 2 (analytical) thinking, and describe when each is typically engaged in clinical decision-making. 
• Identify the most common cognitive biases in veterinary medicine and explain how they can distort clinical judgement. 
• Apply practical strategies to mitigate cognitive biases and interrupt flawed automatic reasoning during consultations. 
• Describe the nature and causes of clinical errors and articulate how they can be used constructively as learning opportunities. 
• Use the Problem-Oriented Medical (POM) approach to systematically identify, assess, and manage multiple concurrent clinical issues. 
• Structure clinical cases using the SOAP format to enhance reasoning clarity, communication, and continuity of care. 
• Conduct a cognitive autopsy of a clinical case to identify key reasoning failures and propose alternative approaches. 
• Integrate structured decision-making tools such as checklists and cognitive pauses into routine practice to enhance diagnostic accuracy. 
• Reflect on their own clinical decisions and demonstrate awareness of uncertainty as a natural and manageable element of veterinary care. 

By the end of this module, the learner will be able to: 

• Justify the appropriate selection of diagnostic tests based on clinical context and patient presentation. 
• Perform and interpret blood smears, recognising normal findings, common artefacts, and pathological changes. 
• Evaluate cytological samples from masses, joints, body cavities, urine, and ear canals to distinguish inflammatory, infectious, and neoplastic processes. 
• Identify limitations in cytological interpretation and determine when further diagnostics, such as biopsies, are indicated. 
• Conduct proper sampling and submission for microbiological culture to maximise diagnostic accuracy and minimise contamination. 
• Interpret culture and sensitivity results critically, integrating them into rational antimicrobial therapy and One Health principles. 
• Demonstrate the technical and interpretive skills required to obtain and analyse thoracic and abdominal radiographs and point-of-care ultrasound (POCUS). 
• Recognise key ECG patterns and artefacts, and identify when ECG findings warrant clinical intervention. 
• Apply safe and effective techniques for placement and management of feeding tubes (NG, NE, oesophagostomy), including nutritional planning. 
• Integrate clinical nutrition into case management, including assessment of caloric needs, dietary selection, and management of obesity. 

By the end of this module, the learner will be able to:

• Differentiate vomiting from regurgitation in dogs and cats based on clinical history, physical examination, and diagnostic testing. 
• Generate a prioritised differential diagnosis list for acute vomiting, incorporating patient signalment and clinical features. 
• Formulate a structured diagnostic and management plan for patients presenting with vomiting, considering both outpatient and hospital-based approaches. 
• Interpret haematological and biochemical abnormalities in the context of vomiting and use them to refine diagnostic hypotheses. 
• Identify common causes of gastric ulceration in small animals and design appropriate treatment protocols. 
• Explain the pathophysiology, clinical presentation, and management strategies for acute and chronic pancreatitis. 
• Evaluate the role of abdominal point-of-care ultrasound (POCUS) in the assessment of vomiting patients, including its indications and limitations. 
• Recognise clinical signs suggestive of toxicological exposure and select appropriate diagnostics to confirm or exclude toxicity as a differential. 
• Devise an evidence-based treatment plan for common toxin ingestions in dogs and cats, considering stabilisation and specific antidotes where applicable. 
• Identify when vomiting may be a manifestation of systemic disease (e.g., Addisonian crisis) and adjust diagnostic priorities accordingly. 

By the end of this module, the learner will be able to: 

• Distinguish between small and large intestinal diarrhoea based on clinical signs, physical examination, and diagnostic findings. 
• Generate differential diagnoses for acute diarrhoea in dogs and cats, categorising by anatomical localisation and disease mechanism. 
• Explain the pathophysiology and clinical implications of chronic enteropathy and dysbiosis, and outline evidence-based therapeutic options. 
• Formulate a stepwise diagnostic and treatment plan for acute and chronic diarrhoea, adapting to case complexity and resource availability. 
• Interpret gastrointestinal-specific biomarker and serological tests, and assess their utility in clinical decision-making. 
• Describe common pharmacological agents used in gastrointestinal disease, including mechanisms of action, indications, and side effects. 
• Evaluate parasitological and bacteriological faecal findings and integrate them into appropriate treatment decisions. 
• Develop treatment plans for protozoal infections such as Giardia and Tritrichomonas in cats and dogs. 
• Incorporate nutritional strategies into the management of patients with diarrhoea, including diet selection and feeding approaches. 
• Identify when diarrhoea may be secondary to extra-intestinal diseases and adjust the diagnostic strategy accordingly. 

By the end of this module, the learner will be able to: 

• Formulate a structured diagnostic plan for dogs and cats presenting with polyuria and polydipsia, including appropriate prioritisation of differential diagnoses. 
• Interpret the results of diagnostic tests used in the evaluation of polyuria and polydipsia, including urinalysis, serum biochemistry, and endocrine assays. 
• Compare the clinical presentation and pathophysiology of diabetes mellitus in dogs and cats and discuss implications for management. 
• Develop a comprehensive treatment and monitoring plan for patients diagnosed with diabetes mellitus, including insulin therapy and dietary modification. 
• Recognise the clinical signs of diabetic ketoacidosis and outline an emergency stabilisation and treatment protocol. 
• Describe the clinical presentation and initial management of hyperosmolar hyperglycaemic states in small animals. 
• Interpret test results and clinical features used in the diagnosis of hyperadrenocorticism and compare diagnostic strategies. 
• Evaluate treatment options for hyperadrenocorticism in dogs, considering drug mechanisms, patient safety, and long-term follow-up. 
• Describe the clinical features and diagnostic approach to feline hyperaldosteronism and explain its relevance to polyuria and polydipsia. 
• Justify nutritional strategies for patients with endocrine disorders that present with polyuria/polydipsia, including diabetes and hyperadrenocorticism. 

By the end of this module, the learner will be able to: 

• Identify anorexia as a non-specific but clinically significant sign and construct a problem-oriented differential diagnosis list across multiple organ systems. 
• Perform a structured clinical evaluation of the anorexic patient, integrating signalment, history, and physical findings to prioritise diagnostic hypotheses. 
• Describe the pathophysiology and clinical relevance of hepatic lipidosis in cats and develop a management plan. 
• Explain the diagnostic approach and long-term treatment for hypothyroidism in dogs, including common diagnostic pitfalls. 
• Evaluate treatment options for feline hyperthyroidism and describe how comorbidities influence therapeutic decisions. 
• Assess the impact of anorexia in patients with systemic disease, including renal, hepatic, and neoplastic conditions. 
• Justify the use of feeding tubes (NG, NE, or oesophagostomy) in the management of anorexia and outline placement techniques and complication management. 
• Construct an appropriate nutritional plan for anorexic patients, including calculating caloric needs and selecting suitable diets. 
• Identify clinical and laboratory features of anaemia-induced anorexia and integrate this into diagnostic planning. 
• Recognise anorexia as an early sign of systemic deterioration and adjust monitoring and intervention accordingly. 

By the end of this module, the learner will be able to: 

• Formulate a structured diagnostic plan for patients presenting with stranguria, haematuria, dysuria, or urinary incontinence. 
• Identify and differentiate the clinical signs and diagnostic features of common lower urinary tract disorders, including urinary tract infections and feline idiopathic cystitis. 
• Design appropriate diagnostic and management strategies for urolithiasis, including struvite and calcium oxalate stones. 
• Interpret urine culture results and distinguish between contamination, asymptomatic bacteriuria, and true infection. 
• Evaluate the causes and treatment options for urinary incontinence in dogs and cats, including urethral sphincter mechanism incompetence (USMI) and ectopic ureters. 
• Recognise the clinical presentation of canine prostatic disease and formulate a diagnostic and treatment plan. 
• Interpret clinical findings indicative of lower urinary tract neoplasia and propose evidence-based management strategies. 
• Develop an emergency and long-term treatment plan for feline ureteric obstruction. 
• Integrate principles of antimicrobial stewardship when managing recurrent or complicated urinary tract infections. 
• Justify the use of advanced imaging techniques in complex or recurrent cases of lower urinary tract disease. 

By the end of this module, the learner will be able to: 

• Interpret red blood cell morphology and complete blood count data to distinguish between regenerative and non-regenerative anaemia. 
• Recognise the clinical and laboratory features of immune-mediated haemolytic anaemia (IMHA) and formulate a diagnostic and treatment plan. 
• Identify the indications and protocols for blood transfusions in small animals, including cross-matching and transfusion reactions. 
• Differentiate causes of thrombocytopenia and justify appropriate diagnostic and therapeutic approaches. 
• Recognise the signs and diagnostic features of coagulopathies and formulate evidence-based treatment plans. 
• Describe the clinical approach to immune-mediated polyarthritis and thrombocytopenia, including appropriate use of immunosuppressive therapy. 
• Identify key infectious agents that may cause anaemia or jaundice in small animals (e.g., haemoplasma, Ehrlichia, FIP) and propose diagnostic strategies. 
• Develop a structured approach to the diagnosis and management of jaundice, including hepatobiliary and haemolytic differentials. 
• Compare and contrast immunosuppressive medications used in the treatment of immune-mediated diseases, including their mechanisms and side effects. 
• Construct a monitoring and long-term management plan for patients diagnosed with immune-mediated or infectious haematological conditions. 

By the end of this module, the learner will be able to: 

• Construct a differential diagnosis list for abdominal distension based on clinical examination and diagnostic imaging findings. 
• Distinguish between different types of abdominal effusion (transudate, modified transudate, exudate, haemorrhagic, chylous) and integrate them into diagnostic planning. 
• Recognise the clinical presentation and emergency management principles of haemoperitoneum in dogs and cats. 
• Identify the clinical features and develop a stabilisation and treatment plan for gastrointestinal obstruction, including foreign bodies. 
• Formulate a diagnostic and therapeutic plan for dogs and cats with suspected acute pancreatitis, incorporating supportive and nutritional care. 
• Interpret imaging findings (radiography and abdominal ultrasound) in cases of abdominal distension and acute abdomen. 
• Develop emergency triage and fluid resuscitation protocols for patients presenting with shock secondary to abdominal pathology. 
• Evaluate the diagnostic and clinical implications of protein-losing enteropathy (PLE) in dogs and cats presenting with abdominal distension. 
• Recognise the abdominal form of feline infectious peritonitis (FIP) and differentiate it from other causes of effusion. 
• Design appropriate follow-up and monitoring strategies for patients recovering from acute abdominal conditions, integrating imaging and laboratory findings. 

By the end of this module, the learner will be able to: 

• Outline a structured diagnostic approach to the coughing or dyspnoeic dog or cat, incorporating history, physical examination, and imaging. 
• Differentiate between upper airway, lower airway, parenchymal, pleural, and mediastinal respiratory disorders based on clinical and radiographic features. 
• Interpret thoracic radiographs and point-of-care ultrasound (POCUS) findings relevant to respiratory disease in dogs and cats. 
• Develop diagnostic and therapeutic strategies for common respiratory conditions including tracheal collapse, feline asthma, and chronic bronchitis. 
• Construct a bronchoalveolar lavage protocol and explain its indications, technique, and limitations. 
• Identify clinical features of pleural space disease and formulate a diagnostic plan to differentiate between effusion types and pneumothorax. 
• Recognise the clinical signs of mediastinal disease and integrate imaging findings into diagnostic reasoning. 
• Formulate an emergency management plan for the dyspnoeic patient, including oxygen therapy and stabilisation techniques. 
• Evaluate infectious causes of respiratory disease, such as canine infectious respiratory disease complex and feline upper respiratory tract infections. 
• Justify antimicrobial use in respiratory disease cases in line with antimicrobial stewardship principles. 

By the end of this module, the learner will be able to: 

• Perform a neurological examination in dogs and cats and interpret deficits to localise the neurological lesion. 
• Evaluate the clinical presentation of a seizuring patient and construct a prioritised differential diagnosis list. 
• Justify diagnostic test selection for patients with seizures or ataxia and interpret results to reach a diagnosis. 
• Formulate an evidence-based treatment plan for status epilepticus, including drug selection, monitoring, and emergency stabilisation. 
• Develop a long-term management plan for patients with epilepsy, considering drug side effects, patient-specific factors, and owner communication. 
• Differentiate between central and peripheral vestibular disease and prioritise diagnostic differentials accordingly. 
• Distinguish seizure from syncope based on history and clinical features and develop an appropriate diagnostic pathway. 
• Recognise infectious and inflammatory diseases that may cause neurological signs in dogs and cats, including toxoplasmosis, cryptococcosis, and FIP. 
• Identify clinical signs and appropriate management strategies for hepatic encephalopathy and describe its relationship to neurological dysfunction. 
• Interpret the clinical features of toxicological neurological presentations and evaluate appropriate treatment options for common toxins. 

By the end of this module, the learner will be able to: 

• Perform fine needle aspiration (FNA) of suspected neoplastic lesions and interpret cytological findings to distinguish between inflammatory and neoplastic processes. 
• Classify cytological patterns (round cell, epithelial, mesenchymal) and evaluate features of malignancy versus benignity. 
• Outline the principles and clinical importance of tumour staging, and justify staging decisions based on case scenarios. 
• Describe the clinical presentation, diagnostic pathway, and treatment considerations for common neoplasms such as mast cell tumours and lymphoma. 
• Design an evidence-based chemotherapy protocol for small animal patients, incorporating drug selection, dosing, side effect management, and monitoring. 
• Recognise safety risks in chemotherapy administration and implement protocols to protect veterinary staff and patients. 
• Interpret clinical signs and diagnostic results supportive of a diagnosis of lower urinary tract neoplasia and outline treatment options. 
• Discuss the role of palliative care and quality-of-life considerations in patients with incurable neoplasia. 
• Evaluate the impact of neoplastic disease on systemic health and integrate supportive care, including nutrition and analgesia. 
• Communicate prognosis and treatment options effectively with pet owners, considering ethical implications and client expectations.

By the end of this module, learners will be able to: 

• Communicate effectively with clients and veterinary team members, adapting their approach to different personality types, emotional contexts, and clinical scenarios. 
• Apply principles of active listening and emotional self-regulation to maintain empathy, clarity, and professionalism during high-pressure consultations. 
• Recognise early signs of occupational stress and burnout, and implement evidence-based strategies to promote personal resilience and wellbeing. 
• Navigate complex or emotionally charged consultations using the Conversational AI simulator, adapting language and tone to improve client understanding and treatment adherence. 
• Reflect on the psychological demands of internal medicine practice and adopt sustainable habits that support long-term emotional health and clinical performance.